Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Lisa M. Augustine"'
Publikováno v:
Drug Metabolism and Disposition. 38:1644-1647
Uptake of drugs and other xenobiotics from the nasal cavity and into either the brain or systemic circulation can occur through several different mechanisms, including paracellular transport and movement along primary olfactory nerve axons, which ext
Autor:
Lisa M. Augustine, James Ranger-Moore, Stephen S. G. Ferguson, Jonathan P. Jackson, Nathan J. Cherrington, Andrew J. Lickteig, Craig D. Fisher
Publikováno v:
Drug Metabolism and Disposition. 37:2087-2094
Members of the cytochrome P450 (P450) enzyme families CYP1, CYP2, and CYP3 are responsible for the metabolism of approximately 75% of all clinically relevant drugs. With the increased prevalence of nonalcoholic fatty liver disease (NAFLD), it is like
Autor:
Nathan J. Cherrington, Lisa M. Augustine, Lauren M. Aleksunes, José E. Manautou, George L. Scheffer
Publikováno v:
Aleksunes, L M, Augustine, L M, Scheffer, G L, Cherrington, N J & Manautou, J E 2008, ' Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment ', Toxicology, vol. 250, no. 2-3, pp. 82-88 . https://doi.org/10.1016/j.tox.2008.06.009
Toxicology, 250(2-3), 82-88. Elsevier Ireland Ltd
Toxicology, 250(2-3), 82-88. Elsevier Ireland Ltd
The goal of this study was to identify alterations in mRNA and protein expression of various xenobiotic transport proteins in mouse kidney during cisplatin-induced acute renal failure. For this purpose, male C57BL/6J mice received a single dose of ci
Autor:
Nathan J. Cherrington, Lisa M. Augustine, Craig D. Fisher, Jonathan P. Jackson, Andrew J. Lickteig
Publikováno v:
Archives of Toxicology. 82:959-964
Non-alcoholic steatohepatitis (NASH) is a disease that compromises hepatic function and the capacity to metabolize numerous drugs. Aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR), pregnane X receptor (PXR), peroxisome prolifer
Autor:
Jonathan P. Jackson, Lisa M. Augustine, Wendong Huang, Matthew D. Merrell, Youcai Zhang, Craig D. Fisher, Jonathan M. Maher, Curtis D. Klaassen, Nathan J. Cherrington, David D. Moore, Angela L. Slitt
Publikováno v:
Drug Metabolism and Disposition. 36:1716-1721
Oltipraz (OPZ) is a well known inducer of NAD(P)H:quinone oxidoreductase (NQO1) along with other enzymes that comprise the nuclear factor E2-related factor 2 (Nrf2) battery of detoxification genes. However, OPZ treatment also induces expression of CY
Publikováno v:
Journal of Biochemical and Molecular Toxicology. 22:128-135
Coordinate regulation of Phase-I and -II enzymes with xenobiotic transporters has been shown after treatment with microsomal enzyme inducers. The chemopreventive agent oltipraz (OPZ) induces Phase-I and -II drug-metabolizing enzymes such as CYP2B and
Autor:
Angela L. Slitt, Nathan J. Cherrington, Craig D. Fisher, Lisa M. Augustine, Andrew J. Lickteig, Lauren M. Aleksunes, José E. Manautou, David G. Besselsen
Publikováno v:
Drug Metabolism and Disposition. 35:1970-1978
Efflux transporters are responsible for the excretion of numerous xenobiotics and endobiotics and thus play an essential role in proper liver and kidney function. Nonalcoholic fatty liver diseases (NAFLDs) comprise a spectrum of disorders that range
Autor:
Michael J. Goedken, George L. Scheffer, Sarah N. Barnes, Lisa M. Augustine, Nathan J. Cherrington, Amy B. Jakowski, José E. Manautou, Lauren M. Aleksunes, Ingrid M. Pruimboom-Brees
Publikováno v:
Drug Metabolism and Disposition. 35:1963-1969
Alterations in transporter expression may represent a compensatory mechanism of damaged hepatocytes to reduce accumulation of potentially toxic compounds. The present study was conducted to investigate the expression of hepatobiliary efflux transport
Autor:
Craig D. Fisher, Robert P. Erickson, Ronald P.J. Oude Elferink, David G. Besselsen, Nathan J. Cherrington, Lisa M. Augustine, Andrew J. Lickteig
Publikováno v:
European journal of pharmacology, 613(1-3), 119-127. Elsevier
Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of diagnoses ranging from simple fatty liver (SFL), to non-alcoholic steatohepatitis (NASH). This study aimed to determine the effect of moderate and severe NAFLD on hepatic transporter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f17547919e8e44f26176f5b7c7309645
https://pure.amc.nl/en/publications/experimental-nonalcoholic-fatty-liver-disease-results-in-decreased-hepatic-uptake-transporter-expression-and-function-in-rats(593780a3-d665-4562-983b-124183262522).html
https://pure.amc.nl/en/publications/experimental-nonalcoholic-fatty-liver-disease-results-in-decreased-hepatic-uptake-transporter-expression-and-function-in-rats(593780a3-d665-4562-983b-124183262522).html
Autor:
Angela L. Slitt, Craig D. Fisher, Lisa M. Augustine, Nathan J. Cherrington, Andrew J. Lickteig, Lauren M. Aleksunes
Publikováno v:
Journal of biochemical and molecular toxicology. 22(2)
In the mammalian liver, there is an abundance of enzymes that function to enable the safe and efficient elimination of potentially harmful xenobiotics that are encountered through environmental exposure. A variety of factors, including gender and gen